Table 2 The ACMG 2015 classifications of prioritized variants (n [%]).

From: Powerful use of automated prioritization of candidate variants in genetic hearing loss with extreme etiologic heterogeneity

 

Human

EVIDENCE

Concordant

Discordant variants

Final candidate variants

Pathogenic

50 (26.31)

55 (28.35)

50 (92.59)

4 (7.41) of EVIDENCE

54 (27.84)

Likely pathogenic

69 (36.32)

67 (34.54)

67 (97.10)

2 (2.90) of humans

69 (35.57)

Variant of uncertain significance

71 (37.37)

72 (37.11)

71 (100.00)

0

71 (36.60)

Total

190

194

188 (96.91)

6 (3.09) (2 of humans and 4 of EVIDENCE)

194